Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999289 | Urologic Oncology: Seminars and Original Investigations | 2016 | 7 Pages |
Abstract
The RARC is becoming more prevalent. In a national cohort, RARC was performed more often on men, with lower stage cancer, who were more likely to receive neoadjuvant chemotherapy. Controlling for these factors, RARC had comparable PSM rates but slightly higher LN yield than ORC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Richard S. M.D., M.S., John Oliver Lang M.D., M.P.H., Adarsh M.D., Jennifer M.D., Shilajit D. M.D., Joshua J. M.D., Ph.D.,